Section Arrow
Quote
ENOV.NYSE
- Enovis Corp
Quotes are at least 15-min delayed:2025/10/23 20:17 EDT
Regular Hours
Last
 32.54
-0.2 (-0.61%)
Day High 
33.27 
Prev. Close
32.74 
1-M High
33.25 
Volume 
696.36K 
Bid
28
Ask
33.8
Day Low
32.39 
Open
32.78 
1-M Low
29.0001 
Market Cap 
1.87B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 31.31 
20-SMA 31 
50-SMA 31.06 
52-W High 49.83 
52-W Low 25.465 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-14.90/5.03
Enterprise Value
3.23B
Balance Sheet
Book Value Per Share
45.10
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
2.11B
Operating Revenue Per Share
29.06
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ITGRInteger Holdings Corp73.89-35.22-32.28%46.63PE
QSIQuantum-Si2.2--0.000%-- 
BSXBoston Scientific Corp102.39-1.46-1.41%62.08PE
PMIPicard Medical Inc13.2+0.03+0.23%-- 
PACBPacific Biosciences of California1.95+0.11+5.98%-- 
Quotes are at least 15-min delayed：2025/10/23 20:17 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.